乳腺癌诊断后临床指征遗传咨询接受率的差距
该研究调查了2013年7月至2015年8月期间在佐治亚州和洛杉矶县SEER登记处报告的20-79岁早期乳腺癌患者,共纳入1711例有正式遗传风险评估指征的患者。结果显示,仅43.5%接受了正式遗传咨询,47.4%未进行检测,未检测者中仅50.6%接受过遗传讨论。年轻女性更可能接受咨询,但遗传专家与医生咨询的信息满意度相似。
要点
- 仅43.5%有临床指征的患者接受正式遗传咨询。
- 未检测者中仅50.6%接受过遗传讨论。
- 年轻女性(<50岁)接受咨询的OR为4.5(95%CI 2.6-8.0)。
核心结论
- 不到一半(43.5%)有临床指征的患者接受了正式遗传咨询。
- 高风险患者及时进行检测前正式遗传咨询的要求与实际实践之间存在巨大差距。
研究设计与样本
- 研究调查了5080名2013年7月至2015年8月诊断的早期乳腺癌患者,来自佐治亚州和洛杉矶县SEER登记处,年龄20-79岁。
- 调查数据与SEER临床数据和基因检测结果链接,最终样本为1711名有正式遗传风险评估指征的患者。
主要发现
- 总体中,47.4%未检测,40.7%检测阴性,7.4%仅意义不明变异,4.5%致病突变。
- 74.6%接受某种形式遗传咨询(43.5%正式咨询,31.1%医生指导讨论)。
- 检测患者中96.1%报告遗传讨论(62.2%正式咨询,33.9%医生指导讨论)。
- 未检测者中仅50.6%接受遗传讨论。
- 控制其他因素后,年轻女性更可能报告咨询:<50岁 vs ≥70岁 OR=4.5(95%CI 2.6-8.0),50-59岁 OR=1.9(95%CI 1.1-3.3),60-69岁 OR=1.5(95%CI 1.0-2.3)。
临床怎么用
- 应加强高风险乳腺癌患者检测前正式遗传咨询的实施,尤其关注未检测人群和老年女性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Purpose Little is known about the extent to which genetic counseling is integrated into community practices for patients newly diagnosed with breast cancer. We examined the receipt of clinically indicated genetic counseling in these patients. Patients and Methods We surveyed 5,080 patients between the ages of 20 and 79 years, diagnosed from July 2013 to August 2015 with early-stage breast cancer and reported to the SEER registries of Georgia and Los Angeles County. Surveys were linked to SEER clinical data and genetic test results. The study sample (N = 1,711) comprised patients with indications for formal genetic risk evaluation. Results Overall, 47.4% did not get tested, 40.7% tested negative, 7.4% had a variant of uncertain significance only, and 4.5% had a pathogenic mutation. Three quarters (74.6%) received some form of genetic counseling (43.5%, formal counseling and 31.1%, physician-directed discussion). Virtually all tested patients (96.1%) reported some form of genetic discussion (62.2%, formal counseling and 33.9%, physician-directed discussion). However, only one half (50.6%) of those not tested received any discussion about genetics. Younger women were more likely to report some type of counseling, controlling for other factors: odds ratio, 4.5 (95% CI, 2.6 to 8.0); 1.9 (95% CI, 1.1 to 3.3); and 1.5 (95% CI, 1.0 to 2.3) for women younger than 50 years of age, 50 to 59 years of age, and 60 to 69 years of age versus those 70 years of age and older. Patients' assessments of the amount of information they received about whether to get tested were similarly high whether they were counseled by a genetics expert or by a physician only (80.8% v 79.4% stated information was just right, P = .59). Conclusion Less than one half (43.5%) of patients with clinical indications received formal genetic counseling. There is a large gap between mandates for timely pretest formal genetic counseling in higher-risk patients and the reality of practice today.
引用
- Katz SJ, Ward KC, Hamilton AS, et al. Gaps in Receipt of Clinically Indicated Genetic Counseling After Diagnosis of Breast Cancer. J Clin Oncol. 2018. PMID: 29528794. doi:10.1200/JCO.2017.76.2369
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。